Amrita Hospital becomes a cut above rest in Cancer Care in India

AACI, America’s Accreditation Major, scripts World’s First Clinical Excellence for Amrita Faridabad

Faridabad / New Delhi: Amrita Hospital in Faridabad aces the race for clinical excellence in Cancer Care. It is all set to become the ‘Standard Bearer’ of oncology in India.

Amrita’s cancer facility now bears the stamp of wisdom of oncologists of 22 countries. It bestows on it ‘Zero Error’ edge in cancer care in comparisons. The quest of this cancer care facility for gold standard is complete with internationally validated protocols, patient safety imperatives and advanced technology integration in place.

AACI (American Accreditation Commission International) has formulated exhaustive standards for comprehensive cancer care. Amrita being the first hospital in the world to get AACI’s clinical excellence certification makes it really a cut above the rest. This certification offers this hospital a vantage position to claim being best in class in cancer care.

Once internationally validated protocols become a culture in cancer care across facilities in India, no cancer patient will have to fly to foreign lands for best care. But for now, many hospitals boasting of high quality cancer care are in fact below par for want of such protocols.

As cancer cases are spiraling in India, a race has begun among corporate hospitals to portray itself as having the best cancer care facility. But in absence of seal of authenticity like that of AACI certification, such claims are taken with a pinch of salt. By formulating this certification after burning midnight oil for one year to derive stringent standards, AACI is poised to usher in new era of clinical excellence in cancer care in India. As oncology is the most abused clinical care in India, there is dire need for such benchmark to be emulated uniformly.

India, one of the world’s most populous nations, confronts an alarming rise in cancer cases across age groups and demographics. Figures of new cases every year and deaths are frightening. With over 1.4 million new cases diagnosed annually and cancer-related deaths reaching nearly 850,000, the burden of oncology care has intensified. Yet, despite the scale and urgency, oncology standards in India have historically remained fragmented, inconsistently implemented, and often overshadowed by operational or commercial challenges.

Lack of stringent oncology standards are resulting in inconsistent treatment protocols , inadequate patient safety measures, variable infrastructure and technology integration, compromised continuity care leading in turn to elevated morbidity and mortality rates, diminished trust in the healthcare system, increased medico legal disputes, institutional reputational damage , financial burden on patients due to inefficiencies and repeat treatments.

Amrita’s example, it is hoped, will lead to emergence of Oncology Standards in India and Thailand land through AACI’s Clinical Excellence Certification (CEC). To address these gaps and redefine the future of oncology care, the American Accreditation Commission International (AACI) has introduced the Clinical Excellence Certification (CEC) in Oncology Standards—a transformative step aimed at standardizing cancer care delivery across India and Southeast Asia.

Thanks to Mr Dheeraj Khatore, CEO & VP – AACI for India & Africa and Board of Director – AACI USA, the Oncology Standards Program under CEC has seen rapid and impactful deployment. This initiative brings India and Thailand on a unified path to clinical excellence in cancer care, incorporating internationally validated protocols, patient safety imperatives, advanced technology integration, and a “Zero Error Policy” ethos.

Talking to Dhananjay Kumar, Managing Editor of Medicare News, Mr. Dheeraj Khatore said: “CEC in Oncology Standards will revolutionize Quality Cancer Care in India. It will leave no room for hospitals to operate below par in oncology services. By introducing a Zero Error Policy through the CEC framework, AACI has raised the bar for clinical performance, patient outcomes, and institutional accountability. AACI’s program is the result of brainstorming of oncologists of 22 countries. We are witnessing a positive revolution—more quality-conscious hospitals are readying to join this movement, committed to providing standardized, ethical, and effective cancer care without compromise.”

Related Posts

Medicines that cure Us are making Our Environment Sick

Antimicrobial Resistance Campaigner makes a Fervent Appeal for Safe Disposal of Leftover Medicines New Delhi: We invariably worry about what might be the side effects of medicines on our body…

ZEN- G packs a punch in Organ Donation as Over 500 Students pledge Organs

National Organ Transplant Games2026 set World Record in Talkatora Indoor Stadium New Delhi: The National Organ Transplant Games began on a high note in Talkatora Indoor Stadium on November 1,…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Cancer drug prices to fall by up to 96% from November 9; consumers set to save Rs 3,502 crore annually

Cancer drug prices to fall by up to 96% from November 9; consumers set to save Rs 3,502 crore annually

Nigeria’s Anti-Narcotics Agency Uncovers Drug Shipments Concealed In Sofas, Snacks, Detergents And Women’s Headwear

Nigeria’s Anti-Narcotics Agency Uncovers Drug Shipments Concealed In Sofas, Snacks, Detergents And Women’s Headwear

FDA seizes food stock worth Rs 63.45 crore, suspends 954 licences in two months

FDA seizes food stock worth Rs 63.45 crore, suspends 954 licences in two months

Stents to syringes: Serious harm reports surge, but makers remain unnamed

Stents to syringes: Serious harm reports surge, but makers remain unnamed

NPPA Revises Retail and Ceiling Prices of 35 Drug Formulations; Fixes Prices of 34 New Drugs, Cholecalciferol, Oxaliplatin and Sun Pharma’s Diclofenac Gel

NPPA Revises Retail and Ceiling Prices of 35 Drug Formulations; Fixes Prices of 34 New Drugs, Cholecalciferol, Oxaliplatin and Sun Pharma’s Diclofenac Gel

ED attaches assets, freezes bank account in counterfeit medicines racket; searches five premises in Bengaluru

ED attaches assets, freezes bank account in counterfeit medicines racket; searches five premises in Bengaluru